SCHEMBL5664969

SCHEMBL5664969

Nc1ccc(N2CCCC(OC(=O)N3C4CCC3CC(O)C4)C2)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.40
MAPT P10636 2/20 0.36
GFER P55789 2/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ACACB O00763 7/20 0.35
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 1/20 0.34
THRB P10828 1/20 0.34
ALOX15 P16050 1/20 0.34
YWHAG P61981 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34
DPP4 P27487 1/20 0.34
DPP8 Q6V1X1 1/20 0.34
DPP9 Q86TI2 1/20 0.34
DPP7 Q9UHL4 1/20 0.34
HTT P42858 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4707591 0.90 ACACB (0.41) ALDH1A1ACACBKDM4EMEN1KMT2A
SCHEMBL5662757 0.88 CHEK1 (0.34) MAPTALDH1A1ACACBDPP4DPP8
SCHEMBL4817742 0.88 ACACB (0.44) MAPTALDH1A1LMNAACACBCHRM2
SCHEMBL4706622 0.87 GAA (0.39) GAAMAPTGFERALDH1A1LMNA
SCHEMBL5661324 0.87 ACACB (0.41) ACACBKDM4EDPP4DPP8DPP9
SCHEMBL5662027 0.85 NOTUM (0.44) ALDH1A1MEN1KMT2AHTT
SCHEMBL5663752 0.85 SLC6A9 (0.42) DPP4DPP8DPP9DPP7CHRM2
SCHEMBL4759493 0.85 ACACB (0.43) MAPTALDH1A1LMNAACACB
SCHEMBL4757342 0.85 HRH3 (0.38) GAAMAPTALDH1A1DPP4DPP8
SCHEMBL14436831 0.85 HRH3 (0.40) ALDH1A1LMNAF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197530-A1 Amido compounds and their use as pharmaceuticals INCYTE CORPORATION 2007-08-23 US claimed
US-20070197530-A1 Amido compounds and their use as pharmaceuticals INCYTE CORPORATION 2007-08-23 US disclosed
US-20070197530-A1 Amido compounds and their use as pharmaceuticals INCYTE CORPORATION 2007-08-23 US disclosed
US-20070197530-A1 Amido compounds and their use as pharmaceuticals INCYTE CORPORATION 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197530-A1 Amido compounds and their use as pharmaceuticals HSD11B1, HSD17B11, CYP11B1 GAA 178/4885MAPT 3520/4885GFER 1135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.